Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Osteoarthritis
•
Orthopedics
•
Sports Medicine
•
Primary Care
How do you counsel patients with autoimmune disease who are considering platelet-rich plasma injections for a musculoskeletal condition unrelated to their autoimmune disease?
Related Questions
Do you avoid hyaluronic acid injections in patients with chondrocalcinosis on imaging?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
Are there any concerns when combining apremilast with azathioprine?
Would you ever consider retreatment with an antiresorptive medication in a patient with a remote history of atypical fracture attributed to an oral bisphosphonate?
How long do you maintain patients with anti-synthetase syndrome on Rituximab?
How do you approach an asymptomatic patient with evidence of intense radiotracer activity at the left sternoclavicular joint on bone scan with a history of SAPHO syndrome on Humira?
What are some of the biggest challenges you run into when patients transition from pediatric to adult care?
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
What are some strategies to help teach patients transitioning from pediatric to adult care to become more independent with respect to their care and less dependent on their caregivers?
